Skip to content

Helen Of Troy HELE Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Clorox logo
CloroxCLX
Newell Brands logo
Newell BrandsNWL
YETI Holdings, Inc. logo
YETI Holdings, Inc.YETI
SharkNinja logo
SharkNinjaSN
Colgate-Palmolive logo
Colgate-PalmoliveCL
Edgewell Personal Care logo
Edgewell Personal CareEPC

Other financials

Income statement

See full
Revenue$470.0M-3.3%
Gross profit$209.7M-11.1%
Operating income-$51.0M-2,629%
Net income-$55.6M-209%
EPS (diluted)-$2.38-207%

Balance sheet

See full
Cash & equivalents$18.9M+0.1%
Total debt$840.7M-12.7%
Total equity$798.2M-52.6%
Total assets$2.1B-32.5%

Cash flow

See full
Operating cash flow$111.3M+218%
CapEx$8.2M+3.8%
Free cash flow$103.1M+281%

Valuation

See full
Market cap$648.22M+5.7%
Enterprise value$1.47B-2.2%
P/S0.4×0.0×

Profitability

See full
Gross margin45.7%-2.3pp
Operating margin-43.8%-51.3pp
Net margin-50.3%-56.8pp
FCF margin6%-3.1pp

Returns & leverage

See full
Return on equity-72.5%-79.9pp
Debt / equity1.1×+0.5×
Current ratio1.7×-0.3×

Where this comes from

Reported directly by Helen Of Troy in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Helen Of Troy’s 10-Q, filed January 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Helen Of Troy's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Helen Of Troy's common stock, shares authorized (in shares)?
Helen Of Troy (HELE) reported common stock, shares authorized (in shares) of $50M in Q3 2025.
How has Helen Of Troy's common stock, shares authorized (in shares) changed year-over-year?
Helen Of Troy's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $50M to $50M.
What is the long-term trend for Helen Of Troy's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Helen Of Troy's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.